<DOC>
	<DOCNO>NCT00467974</DOCNO>
	<brief_summary>The current randomized control trial comparing LEM TACE aim evaluate safety efficacy LEM compare TACE treat patient unresectable HCC .</brief_summary>
	<brief_title>Transarterial Ethanol Ablation ( TEA ) Versus Transcatheter Arterial Chemoembolisation ( TACE ) Hepatocellular Carcinoma</brief_title>
	<detailed_description>The standard loco-regional treatment unresectable hepatocellular carcinoma transarterial chemoembolization ( TACE ) . However , The drawback conventional chemoembolization ( TACE ) liver cancer effectively embolize portal venule supply tumor , therefore chemoembolization difficult completely eradicate tumor . Usually multiple treatment require tumor recurrence common . Transarterial Ethanol Ablation ( LEM ) potentially provide good treatment outcome few treatment session . Preliminary result clinical study show complication rate reduce survival rate may improve . This study aim compare survival duration response rate treatment TACE LEM .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Patient factor Age &gt; 18 ChildPugh A B cirrhosis ECOG performance status Grade 2 No serious concurrent medical illness No prior treatment ( include surgery ) HCC Tumor factor Histologically cytologically proven HCC ( alphafetoprotein level &gt; 500 ug/ml presence radiological finding suggestive HCC patient chronic HBV HCV infection consider eligible investigator 's discretion ) Unresectable locally advance disease without extrahepatic disease Massive expansive nodular tumor morphology measurable lesion CT Size large tumor &lt; = 15cm large dimension Number main tumor &lt; = 5 , exclude associate small satellite lesion . Patient factor History prior malignancy except skin cancer History significant concurrent medical illness ischemic heart disease heart failure History acute tumor rupture Serum creatinine level &gt; 180 umol/L Presence biliary obstruction amenable percutaneous drainage ChildPugh C cirrhosis Evidence poor liver function History hepatic encephalopathy , Intractable ascites controllable medical therapy , History variceal bleeding within last 3 month , Serum total bilirubin level &gt; 50 umol/L , Serum albumin level &lt; 28g/L , INR &gt; 1.3 Tumor factor Presence extrahepatic metastasis Predominantly infiltrative lesion Diffuse tumor morphology extensive lesion involve lobe . Vascular complication Hepatic artery thrombosis , Partial complete thrombosis main portal vein , Tumor invasion portal branch contralateral lobe , Hepatic vein tumor thrombus , Significant arterioportal shunt amenable shunt blockage , Significant arteriovenous shunt amenable shunt blockage</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>